Showing 1 - 7 results of 7 for search 'Zhuoxin Sun', query time: 0.03s
Refine Results
-
1
Chiral phosphoric acid and its applications of asymmetric catalytic hydrogenation by Zhuoxin Sun
Published 2021-01-01
Article -
2
Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational status. by Alessandra Cesano, Santosh Putta, David B Rosen, Aileen C Cohen, Urte Gayko, Kavita Mathi, John Woronicz, Rachael E Hawtin, Larry Cripe, Zhuoxin Sun, Martin S Tallman, Elisabeth Paietta
Published 2013-01-01
Article -
3
Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial by Zhuoxin Sun, Samuel M. Niman, Olivia Pagani, Ann H. Partridge, Hatem A. Azim, Jr., Fedro A. Peccatori, Monica Ruggeri, Angelo Di Leo, Marco Colleoni, Richard D. Gelber, Meredith M. Regan
Published 2020-10-01
Article -
4
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia. by Alessandra Cesano, Cheryl L Willman, Kenneth J Kopecky, Urte Gayko, Santosh Putta, Brent Louie, Matt Westfall, Norman Purvis, David C Spellmeyer, Carol Marimpietri, Aileen C Cohen, James Hackett, Jing Shi, Michael G Walker, Zhuoxin Sun, Elisabeth Paietta, Martin S Tallman, Larry D Cripe, Susan Atwater, Frederick R Appelbaum, Jerald P Radich
Published 2015-01-01
Article -
5
Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 by Franck Rapaport, Kenneth Seier, Yaseswini Neelamraju, Duane Hassane, Timour Baslan, Daniel T. Gildea, Samuel Haddox, Tak Lee, H. Moses Murdock, Caroline Sheridan, Alexis Thurmond, Ling Wang, Martin Carroll, Larry D. Cripe, Hugo Fernandez, Christopher E. Mason, Elisabeth Paietta, Gail J. Roboz, Zhuoxin Sun, Martin S. Tallman, Yanming Zhang, Mithat Gönen, Ross Levine, Ari M. Melnick, Maria Kleppe, Francine E. Garrett-Bakelman
Published 2023-07-01
Article -
6
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 by Franck Rapaport, Kenneth Seier, Yaseswini Neelamraju, Duane Hassane, Timour Baslan, Daniel T. Gildea, Samuel Haddox, Tak Lee, H. Moses Murdock, Caroline Sheridan, Alexis Thurmond, Ling Wang, Martin Carroll, Larry D. Cripe, Hugo Fernandez, Christopher E. Mason, Elisabeth Paietta, Gail J. Roboz, Zhuoxin Sun, Martin S. Tallman, Yanming Zhang, Mithat Gönen, Ross Levine, Ari M. Melnick, Maria Kleppe, Francine E. Garrett-Bakelman
Published 2022-09-01
Article -
7
S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL I... by Mark Litzow, Zhuoxin Sun, Ryan Mattison, Elisabeth Paietta, Charles Mullighan, Kathryn Roberts, Yanming Zhang, Janis Racevskis, Cheryl Willman, Matthew Wieduwilt, Michaela Liedtke, Julie Bergeron, Hillard Lazarus, Dan Arber, Brent Wood, Jacob Rowe, Keith Pratz, Shira Dinner, Noelle Frey, Steve Gore, Bhavana Bhatnagar, Ehab Atallah, Geoff Uy, Deepa Jeyakumar, Tara Lin, Shejal Patel, Michelle Elliott, Anjali Advani, Daniel Deangelo, Dimitrios Tzachanis, Pankit Vachhani, Rupali Bhave, Richard Little, Harry Erba, Richard Stone, Selina Luger, Martin Tallman
Published 2023-08-01
Article